AP2002002496A0 - Method and compositions for treating pulmonary diseases. - Google Patents

Method and compositions for treating pulmonary diseases.

Info

Publication number
AP2002002496A0
AP2002002496A0 APAP/P/2002/002496A AP2002002496A AP2002002496A0 AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0 AP 2002002496 A AP2002002496 A AP 2002002496A AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0
Authority
AP
ARIPO
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
APAP/P/2002/002496A
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP2002002496A0 publication Critical patent/AP2002002496A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

This invention relates to treating pulmonary diseases such as chronic obstructive pulmonary disease or asthma by administering a phosphodiesterase 4 inhibitor in combination with-inflamatory cortcosteroid.
APAP/P/2002/002496A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases. AP2002002496A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
AP2002002496A0 true AP2002002496A0 (en) 2002-06-30

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002496A AP2002002496A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases.

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
SK1862004A3 (en) * 2001-10-31 2004-08-03 Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
BRPI0617673C1 (en) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd phosphodiesterase type iv inhibitor compositions
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710109T3 (en) * 1993-06-18 2005-01-03 Smithkline Beecham Corp Method of Identifying a PDE IV Inhibitor
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
EP1225866A2 (en) 2002-07-31
DZ3225A1 (en) 2001-05-10
BR0015270A (en) 2002-06-18
MXPA02004350A (en) 2002-11-07
WO2001032127A3 (en) 2001-12-06
IL149367A0 (en) 2002-11-10
EA200200518A1 (en) 2002-10-31
CO5261512A1 (en) 2003-03-31
BG106748A (en) 2003-02-28
PE20011005A1 (en) 2001-09-28
CZ20021512A3 (en) 2003-04-16
CN1387404A (en) 2002-12-25
PL355261A1 (en) 2004-04-05
HUP0203152A3 (en) 2004-06-28
HK1049107A1 (en) 2003-05-02
ZA200203435B (en) 2003-06-25
OA12076A (en) 2006-05-04
HUP0203152A2 (en) 2003-01-28
MA26841A1 (en) 2004-12-20
NO20022057L (en) 2002-06-27
ECSP003747A (en) 2002-05-23
AR029189A1 (en) 2003-06-18
SK7592002A3 (en) 2002-11-06
KR20020057988A (en) 2002-07-12
EP1225866A4 (en) 2004-04-21
TWI242431B (en) 2005-11-01
JP2003513028A (en) 2003-04-08
AU1357501A (en) 2001-05-14
CA2388333A1 (en) 2001-05-10
WO2001032127A2 (en) 2001-05-10
NO20022057D0 (en) 2002-04-30
TR200201211T2 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
MY126544A (en) Therapies for treating pulmonary diseases
MXPA04000793A (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma.
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
PL1663185T3 (en) Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
LT2004060A (en) A composition for treating neurocerebrovascular disorders
WO2002088101A3 (en) Inhibitors of bace
MXPA04000328A (en) Statine derivatives for the treatment of alzheimer's disease.
NO20060328L (en) Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders
MXPA04000338A (en) Diaminediols for the treatment of alzheimer's disease.
TNSN04165A1 (en) Substituted hydroxyethylamines
MXPA04002785A (en) Substituted amines for the treatment of alzheimer's disease.
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AP2002002496A0 (en) Method and compositions for treating pulmonary diseases.
WO2002100818A3 (en) Aminediols as agents for the treatment of alzheimer's disease
MXPA03011702A (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
SE9900833D0 (en) Novel combination
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
BG105953A (en) Method for treating copd
SE9900834D0 (en) Novel combination
MXPA04000337A (en) Aminediols for the treatment of alzheimer's disease.